**
Recent research has unveiled concerning findings regarding the presence of per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals,” in umbilical cord blood. A study conducted by researchers at Mount Sinai examined 120 samples and identified 42 different PFAS compounds, significantly higher than previously recognised levels. This discovery raises urgent questions about the potential health risks fetuses face due to these pervasive substances.
Expanded Research Uncovers Hidden PFAS Compounds
Traditionally, testing for PFAS in umbilical cord blood has focused on a limited number of compounds, such as perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). However, the recent study employed a comprehensive “non-targeted analysis” approach, which allowed researchers to detect a broader array of these chemicals. The results revealed that fetuses are likely exposed to a far greater variety of PFAS than previously understood.
Shelley Liu, co-author of the study and associate professor at the Icahn School of Medicine at Mount Sinai, noted, “It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.” This research not only highlights the extent of PFAS exposure but also underscores the potential implications for fetal development and long-term health.
The Health Risks Associated with PFAS Exposure
PFAS are a group of around 15,000 synthetic chemicals widely utilised for their ability to repel water, stains, and grease. They are linked to numerous health issues, including cancer, birth defects, immune system dysfunction, elevated cholesterol levels, and kidney disease. Their resilience in the environment, earning them the moniker “forever chemicals,” compounds the risk as they do not naturally decompose.
Research indicates that elevated PFAS levels in pregnant women correlate with adverse outcomes such as higher infant mortality rates, low birth weights, and a propensity for obesity later in life. Furthermore, prenatal exposure to these substances has been associated with serious health conditions, including cancers, neurological disorders, and cardiovascular diseases in children.
A review encompassing 40 studies found that PFAS were present in 30,000 umbilical cord blood samples, signalling a pervasive contamination issue that demands urgent attention.
Regulatory Challenges and Future Implications
The methods currently employed by regulatory bodies, such as the US Environmental Protection Agency (EPA), have struggled to keep pace with the evolving landscape of PFAS chemicals. The EPA typically tests for only 30 to 40 compounds, while independent researchers have identified thousands in various environments. The recent Mount Sinai study juxtaposed traditional testing against its extensive analysis, revealing a significant underestimation of PFAS levels in fetal blood.
While the EPA has begun certifying tests that can detect up to 53 PFAS compounds, Liu pointed out that 31 compounds identified in the Mount Sinai study were absent from the EPA’s testing parameters. This discrepancy highlights the urgent need for improved regulatory frameworks capable of addressing the complexities of PFAS contamination.
Addressing the Health Implications
Although the study did not directly assess the health effects of PFAS exposure on the fetuses, the correlation between higher PFAS levels and increased health risks is well-documented. The blood samples analysed were part of the federal government’s Home Study, which monitors PFAS exposure and health outcomes over an individual’s life. Researchers involved in the Mount Sinai study are likely to explore the health ramifications of these findings in future investigations.
David Andrews, acting chief science officer at the Environmental Working Group, remarked, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The implications of this research are profound, as they reveal the extent of fetal exposure to harmful chemicals at such a critical developmental stage. As awareness of PFAS contamination grows, the need for stringent regulations and comprehensive testing becomes increasingly urgent to safeguard public health, particularly for vulnerable populations. The findings serve as a clarion call for policymakers and health authorities to take decisive action in mitigating the risks posed by PFAS and ensuring healthier futures for generations to come.
